In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy

Hypertension

Volumn 63, Issue 5, 2014, Pages 1094-1101

  Huda, Shahzya S ^a   Forrest, Rachel ^b   Paterson, Nicole ^b   Jordan, Fiona ^b   Sattar, Naveed ^b   Freeman, Dilys J ^b  

^a FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adipocytes; Lipolysis; Preeclampsia; Pregnancy

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; ESTRADIOL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; INSULIN; INSULIN RECEPTOR; LEPTIN; LEPTIN RECEPTOR; LIPOPROTEIN LIPASE; MESSENGER RNA; PLACENTA LACTOGEN; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADULT; ARTICLE; BIOPSY; CELL SIZE; CELLULAR DISTRIBUTION; CESAREAN SECTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPOLYSIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; LIPOLYSIS; PREECLAMPSIA; PREGNANCY;

ADIPOCYTES; ADULT; BIOPSY; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; ISOPROTERENOL; LEPTIN; LIPOLYSIS; LIPOPROTEIN LIPASE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RECEPTORS, ADRENERGIC, BETA-3; SUBCUTANEOUS FAT; TRIGLYCERIDES;

EID: 84902262545     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01824     Document Type: Article

References (36)

1. Goldberg GR, Prentice AM, Coward W.A., Davies HL, Murgatroyd PR, Wensing C, Black A.E., Harding M., Sawyer M. Longitudinal assessment of energy expenditure in pregnancy by the doubly labeled water method. Am J Clin Nutr. 1993; 57: 494-505. (Pubitemid 23096720)
2. Okereke NC, Huston-Presley L, Amini S.B., Kalhan S., Catalano PM Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab. 2004; 287:E472-E479. (Pubitemid 39095881)
3. Kopp-Hoolihan L.E., van Loan MD, Wong WW, King JC Fat mass deposition during pregnancy using a four-component model. J Appl Physiol (1985). 1999; 87: 196-202. (Pubitemid 29330681)
4. Pipe NG, Smith T, Halliday D., Edmonds CJ, Williams C, Coltart TM Changes in fat, fat-free mass and body water in human normal pregnancy. Br J Obstet Gynaecol. 1979; 86: 929-940. (Pubitemid 10209341)
5. Diderholm B, Stridsberg M, Ewald U., Lindeberg-Nordén S, Gustafsson J. Increased lipolysis in non-obese pregnant women studied in the third trimester. BJOG. 2005; 112: 713-718. (Pubitemid 40852837)
6. Ehrenberg HM, Huston-Presley L, Catalano PM The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol. 2003; 189: 944-948. (Pubitemid 37373874)
7. Sohlström A., Wahlund LO, Forsum E. Total body fat and its distribution during human reproduction as assessed by magnetic resonance imaging. Basic Life Sci. 1993; 60: 181-184.
8. Kinoshita T, Itoh M. Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonography: the ratio of visceral fat to subcutaneous fat in the abdomen. Gynecol Obstet Invest. 2006; 61: 115-118. (Pubitemid 43289485)
9. Einstein FH, Fishman S, Muzumdar R.H., Yang XM, Atzmon G, Barzilai N. Accretion of visceral fat and hepatic insulin resistance in pregnant rats. Am J Physiol Endocrinol Metab. 2008; 294:E451-E455. (Pubitemid 351231474)
10. Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond). 2010; 119: 123-129.
11. Bartha JL, Marín-Segura P, González-González NL, Wagner F, Aguilar-Diosdado M, Hervias-Vivancos B. Ultrasound evaluation of visceral fat and metabolic risk factors during early pregnancy. Obesity (Silver Spring). 2007; 15: 2233-2239. (Pubitemid 350004091)
12. Ijuin H, Douchi T, Nakamura S., Oki T, Yamamoto S, Nagata Y. Possible association of body-fat distribution with preeclampsia. J Obstet Gynaecol Res. 1997; 23: 45-49. (Pubitemid 27120953)
13. Sattar N, Clark P, Holmes A., Lean ME, Walker I, Greer IA Antenatal waist circumference and hypertension risk. Obstet Gynecol. 2001; 97: 268-271. (Pubitemid 32126344)
14. Zhang S, Folsom AR, Flack J.M., Liu K. Body fat distribution before pregnancy and gestational diabetes: findings from coronary artery risk development in young adults (CARDIA) study. BMJ. 1995; 311: 1139-1140.
15. Sattar N, Gaw A, Packard C.J., Greer IA Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br J Obstet Gynaecol. 1996; 103: 614-620. (Pubitemid 26226136)
16. Cottrell EC, Mercer JG Leptin Receptors. Handbook of Experimental Pharmacology. Heidelberg, Germany: Springer. 2012: 3-21.
17. Lipid Research Clinics Program. Lipid and Lipoprotein Analysis. Manual of Laboratory Operations. National Heart and Lung Institute (US). Vol. 1 Publication No. 75-628. 1974.
18. Packard CJ, O'Reilly DS, Caslake MJ, McMahon A.D., Ford I., Cooney J, Macphee CH, Suckling K.E., Krishna M., Wilkinson FE, Rumley A, Lowe GD. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000; 343: 1148-1155.
19. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolsim and lipolysis. J Biol Chem. 1964; 239: 375-380.
20. Martin-Hidalgo A., Holm C, Belfrage P., Schotz MC, Herrera E. Lipoprotein lipase and hormone-sensitive lipase activity and mRNA in rat adipose tissue during pregnancy. Am J Physiol. 1994; 266(6 Pt 1):E930-E935.
21. McLaughlin T, Lamendola C, Coghlan N., Liu TC, Lerner K, Sherman A, Cushman SW Subcutaneous adipose cell size and distribution: relationship to insulin resistance and body fat. Obesity (Silver Spring, Md.). 2013. In Press.
22. Resi V, Basu S, Haghiac M., Presley L, Minium J, Kaufman B., Bernard S, Catalano P, Hauguel-de Mouzon S. Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy. Am J Physiol Endocrinol Metab. 2012; 303:E832-E840.
23. Murai JT, Muzykanskiy E, Taylor RN Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism. 1997; 46: 963-967. (Pubitemid 27339925)
24. Williams C, Coltart TM Adipose tissue metabolism in pregnancy: the lipolytic effect of human placental lactogen. Br J Obstet Gynaecol. 1978; 85: 43-46. (Pubitemid 8375379)
25. Ladyman SR, Augustine RA, Grattan DR Hormone interactions regulating energy balance during pregnancy. J Neuroendocrinol. 2010; 22: 805-817.
26. Mei J, Holst LS, Landström TR, Holm C., Brindley D, Manganiello V, Degerman E. C(2)-ceramide influences the expression and insulinmediated regulation of cyclic nucleotide phosphodiesterase 3B and lipoly-sis in 3T3-L1 adipocytes. Diabetes. 2002; 51: 631-637. (Pubitemid 34760169)
27. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002; 51: 2207-2213. (Pubitemid 34729026)
28. van Harmelen V., Lönnqvist F, Thörne A, Wennlund A., Large V, Reynisdottir S, Arner P. Noradrenaline-induced lipolysis in isolated mes-enteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes Relat Metab Disord. 1997; 21: 972-979. (Pubitemid 27462400)
29. Hammond VA, Johnston DG Substrate cycling between triglyceride and fatty acid in human adipocytes. Metabolism. 1987; 36: 308-313. (Pubitemid 17057910)
30. Catalano PM, Tyzbir ED, Roman N.M., Amini SB, Sims EA Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991; 165(6 Pt 1): 1667-1672.
31. Andersson DP, Löfgren P, Thorell A., Arner P, Hoffstedt J. Visceral fat cell lipolysis and cardiovascular risk factors in obesity. Horm Metab Res. 2011; 43: 809-815.
32. Zierath Jr, Livingston JN, Thörne A, Bolinder J., Reynisdottir S, Lönnqvist F, Arner P. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia. 1998; 41: 1343-1354. (Pubitemid 28488763)
33. Lewis GF, Uffelman KD, Szeto L.W., Weller B., Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 1995; 95: 158-166.
34. Tornvall P, Olivecrona G, Karpe F., Hamsten A, Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol. 1995; 15: 1086-1093.
35. Kalekar SA, Munshi RP, Bhalerao S.S., Thatte UM Insulin sensitizing effect of 3 Indian medicinal plants: an in vitro study. Indian J Pharmacol. 2013; 45: 30-33.
36. Fu Y, Luo N, Klein R.L., Garvey WT Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005; 46: 1369-1379. (Pubitemid 43109800)